Merck & Co., Inc. (MRK) Tops Q4 EPS by 2c; Guides In-Line

February 1, 2013 7:01 AM EST
Merck & Co., Inc. (NYSE: MRK) reported Q4 EPS of $0.83, $0.02 better than the analyst estimate of $0.81. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.46 billion.

Merck & Co., Inc. sees FY2013 EPS of $3.60-3.70, versus the consensus of $3.69.

For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance, Hot Earnings

Related Entities